Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Item
http://www.wikidata.org/entity/Q33536772
Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the FuturePharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insultsA review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependenceNeurochemical and neurostructural plasticity in alcoholism.Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism.Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.Screening Medications for the Treatment of Cannabis Use Disorder.A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in ratsHistamine h3 receptor: a novel therapeutic target in alcohol dependence?Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects.
P2860

Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Item
http://www.wikidata.org/entity/Q33536772
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@ast
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@en
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@nl
type
label
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@ast
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@en
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@nl
prefLabel
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@ast
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@en
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Blockade of the cannabinoid CB ...... and preliminary clinical data.
@en
P2093
P304
P31
P356
10.2174/187152710790966623
P433
P478
P577
P698
P921